Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Osteoarthritis
Use of Autologous Bone Marrow Stem Cell Transplantation for Therapeutic Chondrogenesis in Moderate to Severe Osteoarthritis - ABM & LAM ST-OA Study
Osteoarthritis is a leading cause of chronic disability in elderly and the risk of disability attributed to osteoarthritis is as great as or greater than due to any other medical condition in that age group. Several cross sectional studies have demonstrated an age related increase in the prevalence of osteoarthritis of knee(5). Results of survey are similar with most surgeons reporting 50+ years age group being commonest at initial presentation and that the incidence increases with advancing age. Interestingly some surgeons have noticed earlier occurrence of osteoarthritis in 40+ years age group and one has to be careful to screen for secondary causes in this younger age group patients.
While pain relief is the primary treatment goal of osteoarthritis medications, localized inflammation may also be relieved by using certain drugs. Managing osteoarthritis pain can involve medications, natural remedies, exercise, weight loss, joint protection, mobility aids, assisted devices and more.
Stem cell therapy, using cells extracted from the same patient or suitable alternative human sources, targets diseases which are either incurable or with no complete or effective treatment available in the traditional healthcare system. Since this therapy is based on the concept of regenerating damaged cells in the injured or disease-affected areas of the body, it is called regenerative medicine
Autologous stem cells provide an attractive option for osteoarthritis patients and their clinicians.
In our present study we want to evaluate the safety and efficacy of autologous bone marrow derived stem cells in treatment of Osteoarthritis for therapeutic chondrogenesis through delivery of stem cells into the knee joint space in ten Indian patients.
Studieöversikt
Studietyp
Inskrivning (Förväntat)
Fas
- Fas 2
- Fas 1
Kontakter och platser
Studieorter
-
-
Karnataka
-
Bengaluru, Karnataka, Indien, 560010
- St. Theresa's Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Must be able to give voluntary written (patients may not be able to write) consent.
- Must be able to understand study information provided to him.
- Age 30 to 70, inclusive
- OA Kellgren and Lawrence classification 3 & 4
- No ligamentous laxity i.e. stable
- Ability to understand and willingness to sign consent form
- The participant is able to comply with and understand the required visit schedule and all required tests and procedures.
Exclusion Criteria:
- Serious pre-existing medical conditions like Diabetes Mellitus, Chronic Renal Failure, Rheumatoid Arthritis, Collagen vascular diseases and Autoimmune diseases
- Pregnant or lactating woman
- Inflammatory arthritis
- Oral steroid, methotrexate (immune suppressants)
- History of drug or alcohol abuse or chronic smoking
- Poor patient compliance
- Infectious disease test positive for HIV 1&2, HbsAg, HCV and VDRL.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Autologa benmärgsstamceller
|
Stem cells isolated from the patient's own bone marrow.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Pain as measured by the The Western Ontario and McMaster Universities Arthritis Index (WOMAC) Pain Score
Tidsram: Baseline, 3 months, 6 months, 1 year
|
Baseline, 3 months, 6 months, 1 year
|
|
Antal deltagare med negativa händelser som ett mått på säkerhet och tolerabilitet
Tidsram: 1 år
|
1 år
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Changes in the MRI knee with cartilage mapping and clinical improvement
Tidsram: Baseline, 6 months, 1 year
|
Baseline, 6 months, 1 year
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Rudraprasad, M.S, St. Theresa's Hospital
- Studierektor: Alphy Zachson, M.B.B.S, International Stemcell Services Limited
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- ISSL-AuBM-OA
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .